MedPath

A STUDY OF DHATAKYADI CHURNA (POWDER) IN THE TREATMENT OF BALATISARA (ACUTE DIARRHOEA)

Phase 2
Conditions
Health Condition 1: K529- Noninfective gastroenteritis and colitis, unspecified
Registration Number
CTRI/2021/11/038024
Lead Sponsor
DR MIKHIL TRAMBAKRAO PATI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 PATIENT WITH AGE GROUP OF 1 TO 12 YEARS WILL BE SELECTED

2 PATIENT HAVING ATLEAST 2 TO 3 SYMPTOMS OF BALATISARA ARE AS FOLLOWS

DRAVAMALAPRAVRITTI (STOOL FREQUENCY)

MALASWAROOP (STOOL APPEARANCE)

MUTRAPRAVRITTI (URINE OUTPUT)

SKIN TURGOR

AAHAR (DIETARY INTAKE)

3 PATIENT OF ACUTE DIARRHOEA WITH MILD DEGREE OF DEHAYDRATION

4 PARENTS WILLING FOR PARTICIPATION OF THERE CHILD IN CLINICAL TRIAL AND READY TO GIVE WRITTEN CONSENT

Exclusion Criteria

1 PATIENTS HAVING ANY CHRONIC OR SYSTEMIC ILLNESS

2 PATIENT OF MODRATE TO SEVERE DEHYDRATION AND REQUIRING HOSPITAL IPD MANAGEMENT

3 PATIENTS SYFFERING FROM PRAVAHIKA

4 PATIENTS SUFFERING FROM CHRONIC DIARRHOEA PERSISTENT DIARRHOEA DIARRHOEA DUE TO ACQUIRED OR CONGENITAL IMMUNE DEFICIENCY

5 PATIENT HAVING INTUSSUCEPTIO

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO STUDY THE EFFECT ON DRAVAMALAPRAVRITTITimepoint: DHATAKYADI CHURNA WITH HONEY WILL BE GIVEN ON 0TH AND 3RD DAY FOR THRICE A DAY <br/ ><br>FOLLOW UP WILL BE ON 3RD AND 7TH DAY <br/ ><br>TOTAL DURATION OF STUDY WILL BE 7 DAYS
Secondary Outcome Measures
NameTimeMethod
TO STUDY THE ADVERSE EFFECT OF DHATAKYADI CHURNATimepoint: DHATAKYADI CHURNA WITH HONEY WILL BE GIVEN ON 0TH AND 3RD DAY FOR THRICE A DAY <br/ ><br>FOLLOW UP WILL BE ON 3RD AND 7TH DAY <br/ ><br>TOTAL DURATION OF STUDY WILL BE 7 DAYS
© Copyright 2025. All Rights Reserved by MedPath